Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-15

Clinical Trial Update: Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of adding canagliflozin to insulin in adults with Type 2 Diabetes Mellitus; results were posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Canagliflozin (canagliflozin)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2016-12-15